High-Integrity Primary Packaging by Pharglass | Type I Borosilicate | Ready for Biologics, Vaccines & Advanced Therapies
Pharglass EP 3.2.1 compliant glass vials are engineered to meet the exacting demands of modern biopharmaceutical manufacturing. Fully aligned with European Pharmacopoeia Chapter 3.2.1—the benchmark for glass containers used in parenteral preparations—these vials are manufactured from Type I neutral borosilicate glass to ensure ultra-low leachables, exceptional hydrolytic resistance, and long-term stability for sensitive molecules, including monoclonal antibodies, mRNA vaccines, viral vectors, peptides, and cell & gene therapies.
Available in standard capacities from 2ml to 50ml (2R–50R), our vials feature consistent wall thickness, flat-bottom geometry, and precise dimensional tolerances for seamless integration into automated fill-finish and lyophilization lines. Whether you require non-sterile bulk vials for in-house processing or pre-sterilized Ready-to-Fill (RTF) units, Pharglass offers flexible configurations—including OEM branding and custom packaging—to support clinical trials, commercial launches, and global regulatory submissions (EMA, FDA, NMPA).
Key Features & Benefits
- ✅ Full Compliance with EP 3.2.1 – Essential for EMA dossiers and EU market authorization
- ✅ Type I Borosilicate Glass – Minimizes interaction with pH-sensitive biologics
- ✅ Capacity Range: 2ml–50ml – Scalable from early-phase trials to commercial supply
- ✅ Sterile (SAL 10⁻⁶) or Non-Sterile Options – Gamma or ETO sterilization available
- ✅ OEM Customization – Branding, serialization, color-coded stoppers, and more
- ✅ Global Harmonization – Also meets USP <660> and YBB standards for multi-market filings
Technical Specifications
| Parameter | Specification |
|---|---|
| Product Name | EP 3.2.1 Compliant Biopharma Glass Vials |
| Brand | Pharglass (OEM/private label available) |
| Capacities (ISO Sizes) | 2R (2ml), 5R (5ml), 10R (10ml), 20R (20ml), 30R (30ml), 50R (50ml) |
| Glass Type | Type I Neutral Borosilicate Glass |
| Primary Standard | European Pharmacopoeia 3.2.1 |
| Aligned With | USP <660>, YBB00292005-2-2015, ISO 8362-1 |
| Hydrolytic Resistance | ≤ 0.10 ml 0.01N HCl/g glass (powdered glass test) |
| Color Options | Clear (standard); Amber (UV protection, on request) |
| Neck Finish | Standard ISO finish (e.g., 13mm, 20mm) for bromobutyl stoppers |
| Sterility Options | |
| • Non-sterile: Bulk in clean cartons or nest trays | |
| • Sterile: Gamma/ETO sterilized to SAL 10⁻⁶, double-pouched in RTF trays | |
| Endotoxin Level | <0.25 EU/ml (for sterile versions) |
| MOQ | 5,000 pieces (flexible for OEM programs) |
| Applications | Lyophilized & liquid biologics, mRNA-LNP vaccines, ADCs, enzymes, antibiotics, diagnostic kits |
Why EP 3.2.1 Compliance Matters in Biopharma
The European Pharmacopoeia 3.2.1 sets strict requirements for:
- Chemical durability (hydrolytic resistance)
- Thermal stability
- Freedom from defects (bubbles, cords, stones)
- Dimensional accuracy
Non-compliant containers risk protein aggregation, pH drift, or particulate contamination—critical failure modes for high-value biologics. Pharglass ensures every batch undergoes:
- Batch-specific EP testing
- Automated visual & dimensional inspection
- Helium leak testing for container closure integrity (CCI)
Our vials are already used in EMA-approved biologic products across Europe and beyond.
OEM & Customization Services
As a trusted partner to global pharma, Pharglass offers:
- Private labeling with your logo and product code
- Custom stopper formulations (e.g., fluoropolymer-coated for high-viscosity mAbs)
- Laser serialization or embossed volume markings
- Tailored packaging (nest trays, bulk boxes, RTF configurations)
- Regulatory support: CoA, CoC, DMF, E&L data
Sterile vs. Non-Sterile: Choose Your Workflow
- Non-sterile vials: Ideal for facilities with validated washing/depyrogenation lines
- Sterile RTF vials: Eliminate in-house processing—load directly into aseptic fillers, reduce contamination risk, accelerate time-to-market
Both options maintain full EP 3.2.1 compliance and traceability.
Engineered for Europe. Validated for the world.
When your biologic therapy demands container excellence and regulatory confidence, choose Pharglass EP 3.2.1 compliant glass vials—where science, compliance, and partnership converge.
📩 Contact us today for samples, EP test reports, or a customized quote for your biopharma program!
FA 
EN 
FR 
AR 
DE 
ES 
PT 
RU